XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Research and Development Activity (Details 2) - Immune Ventures to Inmune Bio [Member] - USD ($)
1 Months Ended 6 Months Ended
Mar. 31, 2019
Jun. 30, 2020
Each Phase I initiation [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Payment method of milestone payments $ 50,000 $ 50,000
Each Phase III initiation [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Payment method of milestone payments   500,000
First commercial sale of product making use of licensed technology [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Payment method of milestone payments   $ 1,250,000